February 26, 2015

Dicerna Pharmaceuticals Announces Move to Larger Office and Lab Space in Cambridge, Massachusetts

Relocation Reflects Company’s Continued Growth and Accommodates Future Expansion

Cambridge, Mass., February 26, 2015 – Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi therapeutics, today celebrates the opening of a new 37,000 square-foot office and state-of-the-art research and development (R&D) laboratory at 87 Cambridgepark Drive, in Cambridge’s Alewife neighborhood. Mayor of Cambridge David Maher, Vice Mayor of Cambridge Dennis Benzan, State Representative Jay Livingstone, Massachusetts Life Sciences Center President & CEO Susan Windham-Bannister, Ph.D., and MassBio President & CEO Robert Coughlin will attend a reception and ribbon cutting ceremony at Dicerna this afternoon to mark this important occasion.


Robert Coughlin, President & CEO of MassBio, Dennis A. Benzan, Vice Mayor of Cambridge, Douglas Fambrough, Ph.D., CEO of Dicerna, David P. Maher, Mayor of Cambridge and Susan Windham-Bannister, Ph.D., President & CEO of the Massachusetts Life Sciences Center participate in a ribbon-cutting to celebrate Dicerna’s new facility in Cambridge.